UCSF recently created a sarcoma research group and has worked closely with BeatSarcoma to identify the most impactful projects to fund. BeatSarcoma's Medical Advisory Board reviews all proposals for funding and makes a recommendation to the BeatSarcoma Board of Directors.
From left to right: Nathan Bossett, Nathalie Criou from BeatSarcoma and Dr Eric Nakakura, MD, PhD, UCSF
The money will help fund UCSF translational research laboratory dedicated to understanding basic mechanisms of sarcoma cancer growth - rapid processing is a key element of tissue collection and critical to the quality of molecular research as any lengthy wait or mishandling could lead to cell degradation and wrong conclusions. The UCSF laboratory benefits from a direct line into the operating room and can fully control the way tissue samples are collected and stored or cultivated, thus ensuring cell biological integrity.
Dr Nakakura, MD, PhD in the UCSF translation laboratory
Dr Nakakura, MD PhD, the lead investigator and a cancer surgeon specializing in the treatment of soft tissue sarcoma says: "I'd like to offer my sincere thanks to BeatSarcoma for its tremendous generosity. Please know that our ongoing partnership has a direct impact on our sarcoma studies that we hope will benefit patients in the near future. We greatly appreciate the support!"